Literature DB >> 8680554

Second cancer during long-term survival after resection of biliary tract carcinoma.

S Nakamura1, S Suzuki, T Sakaguchi, H Konno, S Baba, I Kosugi, H Muro.   

Abstract

Curative surgery for biliary tract malignancy has improved the prognosis of patients; however, during long-term follow up after extensive surgery, four of our patients (two with gallbladder carcinoma and two with bile duct carcinoma) developed a second primary cancer (one each in the duodenum, skin, descending colon, and lung). Regular examination of the upper gastrointestinal tract, colorectum, and lungs, and testing for tumor markers (carcinoembryonic antigen and CA19-9) were performed as follow-up studies. As a result, the second cancers were all found at a relatively early stage and all four patients are still alive 6-14 years after the initial operation. A review of the annual autopsy reports over the last 5 years in Japan showed that the incidence of second cancer was 14.8% in patients with gallbladder carcinoma and 13.5% in those with bile duct carcinoma. Furthermore, the rate of second gastric and colorectal carcinoma was significantly higher in patients with primary bile duct cancer than in those with primary gallbladder cancer. In conclusion, the incidence of a second cancer after resection of biliary tract malignancy is more than 10%, but this second cancer can be detected relatively easily and treated at an early stage during the course of regular long-term follow up for the first cancer.

Entities:  

Mesh:

Year:  1996        PMID: 8680554     DOI: 10.1007/bf02389533

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  7 in total

1.  Carcinoma of the main hepatic duct junction: indications, operative morbidity and mortality, and long-term survival.

Authors:  T Tsuzuki; M Ueda; S Kuramochi; S Iida; S Takahashi; H Iri
Journal:  Surgery       Date:  1990-09       Impact factor: 3.982

2.  Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic.

Authors:  R S Houlston; V Murday; C Harocopos; C B Williams; J Slack
Journal:  BMJ       Date:  1990 Aug 18-25

3.  Carcinoma of the gallbladder: staging, treatment, and prognosis.

Authors:  J E Nevin; T J Moran; S Kay; R King
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

4.  The effect of cholecystectomy on bile salt metabolism.

Authors:  E W Pomare; K W Heaton
Journal:  Gut       Date:  1973-10       Impact factor: 23.059

Review 5.  Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review.

Authors:  H T Lynch; T C Smyrk; P Watson; S J Lanspa; J F Lynch; P M Lynch; R J Cavalieri; C R Boland
Journal:  Gastroenterology       Date:  1993-05       Impact factor: 22.682

6.  Cholecystectomy and carcinoma of the colon.

Authors:  D Linos; C M Beard; W M O'Fallon; M B Dockerty; R W Beart; L T Kurland
Journal:  Lancet       Date:  1981-08-22       Impact factor: 79.321

7.  [Prevalence, rate of correct clinical diagnosis and mortality of cancer in 4,894 elderly autopsy cases].

Authors:  K Kuramoto; S Matsushita; Y Esaki; H Shimada
Journal:  Nihon Ronen Igakkai Zasshi       Date:  1993-01
  7 in total
  1 in total

1.  Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA.

Authors:  Xing-Lei Qin; Zhuo-Ren Wang; Jing-Sen Shi; Min Lu; Lin Wang; Quan-Ru He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.